UCLA Drug Information/Investigation Drug — Los Angeles, California

UCLA Drug Information/Investigation Drug is a clinical research site located in Los Angeles, California, United States 90095.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

UCLA Drug Information/Investigation Drug has participated in 1 clinical trials.

Therapeutic areas: Acute Lymphoblastic Leukemia.

Sponsors: Pfizer.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UCLA Drug Information/Investigation Drug?

UCLA Drug Information/Investigation Drug has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UCLA Drug Information/Investigation Drug conducted?

UCLA Drug Information/Investigation Drug has 1 clinical trials on record. Their work covers Acute Lymphoblastic Leukemia.

Is UCLA Drug Information/Investigation Drug accredited by Crixeo Health?

UCLA Drug Information/Investigation Drug has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UCLA Drug Information/Investigation Drug?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.